Table V.

Univariate and multivariate analysis of disease-free survival.

	Univariate analysis			Multivariate analysis
Clinicopathological characteristics	HR	95% CI	P-value	HR	95% CI	P-value
Age at surgery (≥65 vs. <65 years)	0.859	0.482–1.574	0.614	0.968	0.477–1.964	0.927
Tumor location (body-tail vs. head)	0.790	0.382–1.504	0.496	0.797	0.339–1.877	0.604
Pathology (poor vs. well-to-moderate)	2.204	0.927–4.690	0.053	1.350	0.560–3.252	0.504
Tumor stage (III/IV vs. I/II)	0.946	0.503–1.704	0.856	0.833	0.387–1.794	0.641
Lymphocyte (per 100 cells/µl)	0.992	0.933–1.052	0.781	0.939	0.866–1.018	0.129
NLR (per unit)	0.995	0.813–1.187	0.962	1.017	0.751–1.378	0.912
CA19-9 (per 10 U/ml)	1.000	0.997–1.002	0.879	1.001	0.998–1.004	0.471
Cytoplasmic WT1 intensity (moderate-to-strong vs. weak)	2.952	1.610–5.580	<0.001	4.117	1.922–8.817	<0.001

WT1, Wilm's tumor 1; HR, hazard ratio; CI, confidence interval; NLR, neutrophil/lymphocyte ratio; CA19-9, carbohydrate antigen 19-9.